Cargando…

Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany

OVERVIEW: The protective effect of infant pneumococcal conjugate vaccine (PCV) recommendation can be seen in Germany as a whole and in smaller regional groups. Comparisons between population-normalized geographic regions of Germany show different serotype distributions after program implementation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Perniciaro, Stephanie, Imöhl, Matthias, Fitzner, Christina, van der Linden, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326516/
https://www.ncbi.nlm.nih.gov/pubmed/30625215
http://dx.doi.org/10.1371/journal.pone.0210278
_version_ 1783386314449616896
author Perniciaro, Stephanie
Imöhl, Matthias
Fitzner, Christina
van der Linden, Mark
author_facet Perniciaro, Stephanie
Imöhl, Matthias
Fitzner, Christina
van der Linden, Mark
author_sort Perniciaro, Stephanie
collection PubMed
description OVERVIEW: The protective effect of infant pneumococcal conjugate vaccine (PCV) recommendation can be seen in Germany as a whole and in smaller regional groups. Comparisons between population-normalized geographic regions of Germany show different serotype distributions after program implementation, particularly in non-vaccine serotypes. The prior distinct differences in serotype distribution in children between the former East and former West German federal states have vanished. Children under six remain a vulnerable group, but the occurrence of vaccine-type (VT) invasive pneumococcal disease (IPD) in children correctly vaccinated (using a three-dose primary series plus one booster dose) with PCV13 was low (9 out of 374 cases, 2.4%). However, only 18.4% of children in Germany with IPD were correctly vaccinated with PCV13 according to the recommended schedule. Continued surveillance and better schedule adherence are essential to definitively establish the most effective PCV administration schedule. VACCINATION EFFECTS: For all PCV products used in Germany (PCV7, PCV10, and PCV13), vaccination status was the most common statistically significant predictor of infection with a particular serotype: Unvaccinated children old enough to have received at least one dose of vaccine in the PCV7 group had significantly higher odds (OR: 6.84, 95%CI: 2.66–22.06, adjusted for per capita income and residence in the northeastern federal states) of contracting VT IPD. In the PCV10 group, VT IPD had an OR of 4.52 (95% CI: 1.60–15.62, adjusted for year of infection, median household size, and residence in the southern federal states) in unvaccinated children, and in the PCV13 group, unvaccinated children continued to have higher odds (OR: 6.21, 95%CI: 3.45–11.36, adjusted for year of infection, age of child, per capita income, residence in the southern federal states, and percentage of children using public daycare) of getting vaccine-type IPD. Being unvaccinated was the most frequent significant indicator for infection with vaccine-type serotypes for each analysis group, while geographic groupings showed more limited potential to predict serotype of infection in early childhood IPD in Germany.
format Online
Article
Text
id pubmed-6326516
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63265162019-01-18 Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany Perniciaro, Stephanie Imöhl, Matthias Fitzner, Christina van der Linden, Mark PLoS One Research Article OVERVIEW: The protective effect of infant pneumococcal conjugate vaccine (PCV) recommendation can be seen in Germany as a whole and in smaller regional groups. Comparisons between population-normalized geographic regions of Germany show different serotype distributions after program implementation, particularly in non-vaccine serotypes. The prior distinct differences in serotype distribution in children between the former East and former West German federal states have vanished. Children under six remain a vulnerable group, but the occurrence of vaccine-type (VT) invasive pneumococcal disease (IPD) in children correctly vaccinated (using a three-dose primary series plus one booster dose) with PCV13 was low (9 out of 374 cases, 2.4%). However, only 18.4% of children in Germany with IPD were correctly vaccinated with PCV13 according to the recommended schedule. Continued surveillance and better schedule adherence are essential to definitively establish the most effective PCV administration schedule. VACCINATION EFFECTS: For all PCV products used in Germany (PCV7, PCV10, and PCV13), vaccination status was the most common statistically significant predictor of infection with a particular serotype: Unvaccinated children old enough to have received at least one dose of vaccine in the PCV7 group had significantly higher odds (OR: 6.84, 95%CI: 2.66–22.06, adjusted for per capita income and residence in the northeastern federal states) of contracting VT IPD. In the PCV10 group, VT IPD had an OR of 4.52 (95% CI: 1.60–15.62, adjusted for year of infection, median household size, and residence in the southern federal states) in unvaccinated children, and in the PCV13 group, unvaccinated children continued to have higher odds (OR: 6.21, 95%CI: 3.45–11.36, adjusted for year of infection, age of child, per capita income, residence in the southern federal states, and percentage of children using public daycare) of getting vaccine-type IPD. Being unvaccinated was the most frequent significant indicator for infection with vaccine-type serotypes for each analysis group, while geographic groupings showed more limited potential to predict serotype of infection in early childhood IPD in Germany. Public Library of Science 2019-01-09 /pmc/articles/PMC6326516/ /pubmed/30625215 http://dx.doi.org/10.1371/journal.pone.0210278 Text en © 2019 Perniciaro et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Perniciaro, Stephanie
Imöhl, Matthias
Fitzner, Christina
van der Linden, Mark
Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany
title Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany
title_full Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany
title_fullStr Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany
title_full_unstemmed Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany
title_short Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany
title_sort regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in germany
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326516/
https://www.ncbi.nlm.nih.gov/pubmed/30625215
http://dx.doi.org/10.1371/journal.pone.0210278
work_keys_str_mv AT perniciarostephanie regionalvariationsinserotypedistributionandvaccinationstatusinchildrenundersixyearsofagewithinvasivepneumococcaldiseaseingermany
AT imohlmatthias regionalvariationsinserotypedistributionandvaccinationstatusinchildrenundersixyearsofagewithinvasivepneumococcaldiseaseingermany
AT fitznerchristina regionalvariationsinserotypedistributionandvaccinationstatusinchildrenundersixyearsofagewithinvasivepneumococcaldiseaseingermany
AT vanderlindenmark regionalvariationsinserotypedistributionandvaccinationstatusinchildrenundersixyearsofagewithinvasivepneumococcaldiseaseingermany